Latest C-peptide Stories
SAN FRANCISCO, July 11 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc.
Osiris Therapeutics, Inc.
MONTREAL, QUEBEC--(Marketwire - June 19, 2008) - Ambrilia Biopharma Inc. (TSX:AMB) today reported that it demonstrated and validated the in vivo proof-of-concept with its NGR-delivery technology applied to a carrier containing a siRNA (small interfering RNA).
SAN FRANCISCO, June 18 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc.
The Scandinavian-based drug development company Lytix Biopharma revealed more information on its lead anti-cancer molecule Oncopore at BIO 2008 in San Diego.
By Lee, Seung-Hwan Kim, Mee-Ran; Kim, Ji-Hyun; Kwon, Hyuk-Sang; Et al Abstract We report a patient with combined polycystic ovary syndrome (PCOS) and autoimmune polyglandular syndrome (APS) type 2. A 26-year-old female presented with polyuria, polydipsia and acute weight loss.